UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract 18238: Transition from Vitamin-K-antagonists to New Oral Anticoagulants in Daily Care - First Results of the Prospective NOAC Registry (NCT 01588119)

Circulation (New York, N.Y.), 2012-11, Vol.126 (suppl_21)

2012

Volltextzugriff (PDF)

Real Life Efficacy and Safety of Rivaroxaban for Acute VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119)

Blood, 2012-11, Vol.120 (21), p.1159-1159

2012

Volltextzugriff (PDF)

Real Life Efficacy and Safety of Rivaroxaban for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Blood, 2012-11, Vol.120 (21), p.1156-1156

2012

Volltextzugriff (PDF)

Real Life Efficacy and Safety of Rivaroxaban for Extended VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119)

Blood, 2012-11, Vol.120 (21), p.2267-2267

2012

Volltextzugriff (PDF)

Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119)

Blood, 2012-11, Vol.120 (21), p.1173-1173

2012

Volltextzugriff (PDF)

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Blood, 2012-11, Vol.120 (21), p.502-502

2012

Volltextzugriff (PDF)

The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney disease

International journal of cardiology, 2018-02, Vol.253, p.71-77

2018

Volltextzugriff (PDF)

In Reply

Deutsches Ärzteblatt international, 2019-06, Vol.116 (23-24), p.420

Beyer-Westendorf, Jan

2019

Volltextzugriff (PDF)

In Reply

Deutsches Ärzteblatt international, 2019-06, Vol.116 (23-24), p.420-421

Beyer-Westendorf, Jan

2019

Volltextzugriff (PDF)

Correspondence (reply): In Reply

Deutsches Ärzteblatt international, 2019-06, Vol.116 (23-24), p.420-421

Beyer-Westendorf, Jan

2019

Volltextzugriff (PDF)

Blutgerinnung und hormonelle Kontrazeptiva

Gynäkologische Endokrinologie, 2022-01, Vol.20 (4), p.263-271

2022

Volltextzugriff (PDF)

NOAC Therapy Is Also Effective and Safe in Patients Older Than 80 Years — Results of the Prospective Dresden NOAC Registry (NCT01588119)

Blood, 2018-11, Vol.132 (Supplement 1), p.422-422

2018

Volltextzugriff (PDF)

A REAL-WORD, PROSPECTIVE OBSERVATIONAL STUDY TO COMPARE RIVAROXABAN VERSUS VITAMIN K ANTAGONIST TREATMENT IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND ADVANCED CHRONIC KIDNEY DISEASE

Journal of the American College of Cardiology, 2022-03, Vol.79 (9), p.201

2022

Volltextzugriff (PDF)

Outcome of Noac Exposure during Pregnancy (...and the problem of event reporting...)

Blood, 2015-12, Vol.126 (23), p.1125-1125

2015

Volltextzugriff (PDF)

Anticoagulant therapy for splanchnic vein thrombosis

Journal of thrombosis and haemostasis, 2020-07, Vol.18 (7), p.1562-1568

2020

Volltextzugriff (PDF)

Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor-Related Atraumatic Intracerebral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care

Stroke (1970), 2022-02, Vol.53 (2), p.532-543

2022

Volltextzugriff (PDF)

579 The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Sub-Analysis

The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S332-S333

2019

Volltextzugriff (PDF)

Abstract 13927: Advanced Age and Preferential Use of Vitamin K Antagonists in Severe Renal Impairment: First Results of the XARENO Registry in Patients With Non-valvular Atrial Fibrillation and Non-dialysis Dependent Advanced Chronic Kidney Disease

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A13927-A13927

2020

Volltextzugriff (PDF)

Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: The Improve-VTE Study

Blood, 2018-11, Vol.132 (Supplement 1), p.1241-1241

2018

Volltextzugriff (PDF)

Severe Hemorrhage Associated With Oral Anticoagulants

Deutsches Ärzteblatt international, 2020-05

2020

Volltextzugriff (PDF)

Pattern and Management of Intracranial Haemorrhage with Rivaroxaban or Dabigatran Compared to Vitamin K Antagonists - Results of the Prospective Dresden Noac Registry

Blood, 2015-12, Vol.126 (23), p.1127-1127

2015

Volltextzugriff (PDF)

Pattern and Management of Vaginal Bleeding Complications, Especially Hypermenorrhea, with Direct Oral Anticoagulants - Results of the Prospective Dresden Noac Registry (NCT01588119)

Blood, 2015-12, Vol.126 (23), p.1131-1131

2015

Volltextzugriff (PDF)

Pattern and Management of ISTH Major Bleeding Complications with Direct Oral Anticoagulants - Results of the Prospective Dresden Noac Registry (NCT01588119)

Blood, 2015-12, Vol.126 (23), p.892-892

2015

Volltextzugriff (PDF)

Effectiveness and Safety of Rivaroxaban Versus Warfarin for Treatment of Venous Thromboembolism in Patients with Known Primary Hypercoagulable States

Blood, 2017-12, Vol.130, p.1113-1113

2017

Volltextzugriff (PDF)

Splanchnic Vein Thrombosis Treatment with Rivaroxaban - a Case Series from the Prospective Dresden Noac Registry (NCT01588119)

Blood, 2017-12, Vol.130, p.1109-1109

2017

Volltextzugriff (PDF)

26 – 50 von 98

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(96)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(80)
Deutsch
(17)

Erscheinungsjahr

n.n

Thema

Humans
(13)
Female
(7)
Male
(6)
Treatment Outcome
(6)
Aged
(5)
Venous Thrombosis
(5)
Anticoagulants
(4)
Anticoagulants - Adverse Effects
(4)
Anticoagulation
(4)
Atrial Fibrillation
(4)
Hematology, Oncology And Palliative Medicine
(4)
Medicine & Public Health
(4)
Middle Aged
(4)
Original
(4)
Original Article
(4)
Prospective Studies
(4)
Time Factors
(4)
Venous Thromboembolism
(4)
Administration, Oral
(3)
Aged, 80 And Over
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract 18238: Transition from Vitamin-K-antagonists to New Oral Anticoagulants in Daily Care - First Results of the Prospective NOAC Registry (NCT 01588119)

Real Life Efficacy and Safety of Rivaroxaban for Acute VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119)

Real Life Efficacy and Safety of Rivaroxaban for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Real Life Efficacy and Safety of Rivaroxaban for Extended VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119)

Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119)

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney disease

In Reply

In Reply

Correspondence (reply): In Reply

Blutgerinnung und hormonelle Kontrazeptiva

NOAC Therapy Is Also Effective and Safe in Patients Older Than 80 Years — Results of the Prospective Dresden NOAC Registry (NCT01588119)

A REAL-WORD, PROSPECTIVE OBSERVATIONAL STUDY TO COMPARE RIVAROXABAN VERSUS VITAMIN K ANTAGONIST TREATMENT IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND ADVANCED CHRONIC KIDNEY DISEASE

Outcome of Noac Exposure during Pregnancy (...and the problem of event reporting...)

Anticoagulant therapy for splanchnic vein thrombosis

Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor-Related Atraumatic Intracerebral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care

579 The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Sub-Analysis

Abstract 13927: Advanced Age and Preferential Use of Vitamin K Antagonists in Severe Renal Impairment: First Results of the XARENO Registry in Patients With Non-valvular Atrial Fibrillation and Non-dialysis Dependent Advanced Chronic Kidney Disease

Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: The Improve-VTE Study

Severe Hemorrhage Associated With Oral Anticoagulants

Pattern and Management of Intracranial Haemorrhage with Rivaroxaban or Dabigatran Compared to Vitamin K Antagonists - Results of the Prospective Dresden Noac Registry

Pattern and Management of Vaginal Bleeding Complications, Especially Hypermenorrhea, with Direct Oral Anticoagulants - Results of the Prospective Dresden Noac Registry (NCT01588119)

Pattern and Management of ISTH Major Bleeding Complications with Direct Oral Anticoagulants - Results of the Prospective Dresden Noac Registry (NCT01588119)

Effectiveness and Safety of Rivaroxaban Versus Warfarin for Treatment of Venous Thromboembolism in Patients with Known Primary Hypercoagulable States

Splanchnic Vein Thrombosis Treatment with Rivaroxaban - a Case Series from the Prospective Dresden Noac Registry (NCT01588119)

Aktive Filter

Suchergebnisse filtern